"The effect of tripeptide-copper complex on human hair growth in vitro." Archives of Pharmacal Research, 30(7), 834839
In 2014, the FDA granted AOD 9604 Human GRAS (Generally Recognized As Safe) status, indicating a favorable safety profile when used as directed

Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Should not be used alongside other GLP-1 receptor medications Gastric emptying may be delayed, requiring caution for procedures involving sedation or general anesthesia due to aspiration risk Use caution in those with a history of diabetic retinopathy 1-3 Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions Avoid use during pregnancy and breastfeeding 1 Enhances glucose-dependent insulin secretion Suppresses glucagon secretion Slows gastric emptying Influences brain regions involved in appetite regulation, leading to reduced hunger and caloric intake Improves insulin sensitivity 1-3 Supports weight loss Helps to minimize internal inflammation and improves cardiometabolic health measures 5 Q: How long does it take to see results
%20157%3F)
Regulatory toxicology and pharmacology : RTP , 114 , 104665
HPLC purity 99 % documented, not just claimed HPLC purity shows what proportion of the powder is actually BPC-157
Unlike most clinics we do not charge extra for this invaluable service